Literature DB >> 6159636

Liver tumors distinguished by immunofluorescence microscopy with antibodies to proteins of intermediate-sized filaments.

P Bannasch, H Zerban, E Schmid, W W Franke.   

Abstract

Antibodies against constitutive proteins of different types of intermediate-sized filaments were used in immunofluorescence microscopy on frozen sections of normal rat liver and various rat liver tumors induced by treatment with nitrosamines. Antibodies to tonofilament prekeratin stained bile duct epithelia and hepatocytes of normal liver and hepatocellular carcinoma cells and ductal cells of cholangiofibromas. These cells were not significantly stained by antibodies to vimentin. By contrast, antibodies to vimentin stained mesenchymal cells of normal liver and cells of early and advanced angiosarcomas and of undifferentiated spindle cell sarcoma. These mesenchymal tumor cells were not stained with antibodies to prekeratin. The presence of intermediate-sized filaments in these tumors, often in large whorl-like aggregates, was also demonstrated by electron microscopy. The results show that immunofluorescence microscopy with antibodies to cytoskeletal proteins is a powerful tool for the classification and differential diagnosis of mesenchymal and epithelial liver tumors. We propose that staining with antibodies to proteins of different types of intermediate filaments can be used to improve the identification of tumors of other organs, including metastases, as well as non-neoplastic proliferative lesions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159636      PMCID: PMC349966          DOI: 10.1073/pnas.77.8.4948

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat.

Authors:  E Scherer; P Emmelot
Journal:  Eur J Cancer       Date:  1975-10       Impact factor: 9.162

2.  [Histogenesis and cytogenesis of cholangiofibromas and cholangiocarcinomas in nitrosomorpholine-intoxicated rats (author's transl)].

Authors:  P Bannasch; B Massner
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-12-09

3.  [Fine structure of cholangiofibromas induced in the rat by n-nitrosomorpholine (author's transl)].

Authors:  P Bannasch; B Massner
Journal:  Virchows Arch B Cell Pathol       Date:  1977-09-15

4.  In vitro demonstration of Mallory body formation in liver cells from rats fed diethylnitrosamine.

Authors:  E Borenfreund; A Bendich
Journal:  Lab Invest       Date:  1978-03       Impact factor: 5.662

5.  10 nm filaments in normal and transformed cells.

Authors:  R O Hynes; A T Destree
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

6.  Ultrastructure of bile canaliculi, with special reference to the surface coat and the pericanalicular web.

Authors:  M Oda; V M Price; M M Fisher; M J Phillips
Journal:  Lab Invest       Date:  1974-10       Impact factor: 5.662

7.  Structure of a hepatoblastoma of pure epithelial type.

Authors:  F Gonzalez-Crussi; H J Manz
Journal:  Cancer       Date:  1972-05       Impact factor: 6.860

8.  Hepatoblastoma and hepatoma in infancy and childhood. Light and electron microscopic studies.

Authors:  J Ito; W W Johnson
Journal:  Arch Pathol       Date:  1969-03

9.  Fine structure of transplantable hepatomas of the rat.

Authors:  Z Hruban; H Swift; M Rechcigl
Journal:  J Natl Cancer Inst       Date:  1965-09       Impact factor: 13.506

10.  Distribution of actin and tubulin in cells and in glycerinated cell models after treatment with cytochalasin B (CB).

Authors:  K Weber; P C Rathke; M Osborn; W W Franke
Journal:  Exp Cell Res       Date:  1976-10-15       Impact factor: 3.905

View more
  25 in total

Review 1.  Intermediate filaments: a historical perspective.

Authors:  Robert G Oshima
Journal:  Exp Cell Res       Date:  2007-04-11       Impact factor: 3.905

2.  Cytokeratin polypeptides expression in different epithelial elements of human salivary glands.

Authors:  S Geiger; B Geiger; O Leitner; G Marshak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 3.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors.

Authors:  W Schürch; O Skalli; T A Seemayer; G Gabbiani
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

5.  Identification of the conserved, conformation-dependent cytokeratin epitope recognized by monoclonal antibody (lu-5).

Authors:  W W Franke; S Winter; J von Overbeck; F Gudat; P U Heitz; C Stähli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 6.  The role of cytoskeletal and cytocontractile elements in pathologic processes.

Authors:  E Rungger-Brändle; G Gabbiani
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

7.  Differentiation of cell types in the mammalian kidney by immunofluorescence microscopy using antibodies to intermediate filament proteins and desmoplakins.

Authors:  S Bachmann; W Kriz; C Kuhn; W W Franke
Journal:  Histochemistry       Date:  1983

8.  Esthesioneuroblastoma: ultrastructural, immunohistological and biochemical investigation of one case.

Authors:  M Vollrath; M Altmannsberger; D H Hunneman; H H Goebel; M Osborn
Journal:  Arch Otorhinolaryngol       Date:  1984

9.  Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors.

Authors:  H Denk; R Krepler; U Artlieb; G Gabbiani; E Rungger-Brändle; P Leoncini; W W Franke
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

10.  The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.

Authors:  G A Blobel; R Moll; W W Franke; K W Kayser; V E Gould
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.